
The Cooper Companies, Inc. (Cooper, we or the Company), is a leading global medical device company focused on helping people experience life's beautiful moments. Headquartered in San Ramon, California, Cooper sells products in over 130 countries and positively impacts over fifty million lives each year. Cooper operates through two business segments, CooperVision and CooperSurgical. Our two business segments elevate standards of care with products and services in the fields of vision, fertility and women's health. For financial information relating to these business segments, refer to Note 12. Business Segment Information in Item 8. Financial Statements and Supplementary Data of this Annual Report. CooperVision is a global manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. CooperVision designs its products to address vision challenges such as astigmatism, presbyopia and myopia with a broad collection of spherical, toric and multifocal contact lenses. CooperVision offers contact lenses in materials like silicone hydrogel Aquaform technology.
Logo and founding year from Wikidata.
As recorded by the SEC for this filer.
As recorded by the SEC for this filer.
No peers found.
No related securities.
No peers found.
No related securities.
| Oct FY2014 | 1.7B |
|---|---|
| Oct FY2015 | 1.8B |
| Oct FY2016 | 2B |
| Oct FY2017 | 2.1B |
| Oct FY2018 | 2.5B |
| Oct FY2019 | 2.7B |
| Oct FY2020 | 2.4B |
| Oct FY2021 | 2.9B |
| Oct FY2022 | 3.3B |
| Oct FY2023 | 3.6B |
| Oct FY2024 | 3.9B |
| Oct FY2025 | 4.1B |
| Jul Q3 FY23 | 930.2M |
|---|---|
| Oct Q4 FY23 | 927.1M |
| Jan Q1 FY24 | 931.6M |
| Apr Q2 FY24 | 942.6M |
| Jul Q3 FY24 | 1B |
| Oct Q4 FY24 | 1B |
| Jan Q1 FY25 | 964.7M |
| Apr Q2 FY25 | 1B |
| Jul Q3 FY25 | 1.1B |
| Oct Q4 FY25 | 1.1B |
| Jan Q1 FY26 | 1B |
| Apr Q2 FY26 | 1.1B |